Back to Search
Start Over
A long-term follow-up study after split-course irradiation with concurrent chemotherapy (carboplatin) for locally advanced head and neck cancer and a review of the literature.
- Source :
-
ORL; journal for oto-rhino-laryngology and its related specialties [ORL J Otorhinolaryngol Relat Spec] 2004; Vol. 66 (6), pp. 325-31. - Publication Year :
- 2004
-
Abstract
- Background: Radiotherapy is often the primary treatment for advanced head and neck cancer, but the rates of locoregional recurrence are high and survival is poor. The purpose of this study was to evaluate the efficacy and toxicity of split-course radiotherapy combined with concurrent carboplatin chemotherapy after long-term follow-up.<br />Patients and Methods: From August 1987 to May 1994, 66 patients (54 males, 12 females, mean age 58 years) with advanced inoperable oropharynx cancer were treated at the University of Göttingen, Göttingen, Germany. Tumour localization in the oropharynx was: tonsil (n = 33), base of tongue (n = 28), soft palate (n = 2) and posterior pharyngeal wall (n = 3). Forty-nine patients presented with a T(4) tumour, 15 were T(3) and 2 were T(2). The nodal status was distributed as follows: N0 (n = 7), N1 (n = 5), N2 (n = 28) and N3 (n = 26). A total radiation dose of 5,670 cGy was applied in 6 weeks as a split-course regimen (2 x 2.1 Gy/day, 4 times a week, weeks 1 and 2 and weeks 5 and 6). Concomitant carboplatin chemotherapy was given each radiotherapy day before irradiation (50 mg/m(2)).<br />Results: In December 2003, 12 patients were still alive. Survivors have reached a maximum follow-up of 170.5 months (median 14.3 months). Two- and 5-year overall survival was 32 and 18%, 2-year disease-free survival 27%. Therapy was tolerated moderately (19% grade 3 skin reaction, 26% grade 3 mucositis, 23% grade 3 xerostomia, 20% grade 3 leucopenia, 8% grade 3 thrombopenia and 25% grade 3 anaemia).<br />Conclusion: Split-course radiotherapy and concomitant carboplatin chemotherapy can be carried out in inoperable head and neck cancer without severe toxicity. After long-term follow-up, survival rates are unfavourable in this poor prognostic group of patients.<br /> (Copyright (c) 2004 S. Karger AG, Basel.)
- Subjects :
- Adult
Aged
Antineoplastic Agents adverse effects
Carboplatin adverse effects
Chemotherapy, Adjuvant methods
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
Middle Aged
Prognosis
Radiotherapy, Adjuvant methods
Treatment Outcome
Antineoplastic Agents therapeutic use
Carboplatin therapeutic use
Carcinoma, Squamous Cell therapy
Head and Neck Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0301-1569
- Volume :
- 66
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- ORL; journal for oto-rhino-laryngology and its related specialties
- Publication Type :
- Academic Journal
- Accession number :
- 15668532
- Full Text :
- https://doi.org/10.1159/000081890